BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22435263)

  • 1. 18F-FDG avid in uterine leiomyoma: a case report.
    Chiewvit S
    J Med Assoc Thai; 2012 Feb; 95(2):288-92. PubMed ID: 22435263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
    Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
    Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.
    Yamane T; Takaoka A; Kita M; Imai Y; Senda M
    Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-fluorodeoxyglucose uptake in uterine leiomyomas in healthy women.
    Tsukada H; Murakami M; Shida M; Kikuchi K; Watanabe M; Yasuda S; Suzuki Y
    Clin Imaging; 2009; 33(6):462-7. PubMed ID: 19857807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Hypermetabolism of Benign Uterine Leiomyoma on 18F-FDG PET/CT.
    Nunes RF; Queiroz MA; Buchpiguel CA; Carvalho FM; Carvalho JP
    Clin Nucl Med; 2019 Jun; 44(6):e413-e414. PubMed ID: 30985441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
    Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
    J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy.
    Falchi L; Capello D; Palumbo B; Rauco A; Emili R; Cianciulli M; Pace R; Capparella V; Liberati F; Liberati AM
    Eur J Haematol; 2007 Nov; 79(5):455-61. PubMed ID: 17908180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and characteristics of uterine leiomyomas with FDG uptake.
    Nishizawa S; Inubushi M; Kido A; Miyagawa M; Inoue T; Shinohara K; Kajihara M
    Ann Nucl Med; 2008 Nov; 22(9):803-10. PubMed ID: 19039559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET.
    Yoshida Y; Kiyono Y; Tsujikawa T; Kurokawa T; Okazawa H; Kotsuji F
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1824-31. PubMed ID: 21656049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
    Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
    J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign metastasizing leiomyoma of the lung: PET findings.
    di Scioscio V; Feraco P; Miglio L; Toni F; Malvi D; Pacilli AM; Fasano L; Fabbri M; Zompatori M
    J Thorac Imaging; 2009 Feb; 24(1):41-4. PubMed ID: 19242303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case of uterine leiomyoma showing fludeoxyglucose uptake on F-18 fludeoxyglucose positron emission tomography/computed tomography.
    Park JH; Han JY; Hyun IY; Lee BI; Moon YS
    J Obstet Gynaecol Res; 2010 Dec; 36(6):1261-4. PubMed ID: 21083837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT findings in uterine leiomyomas.
    Jehanno N; Wartski M; Malhaire C; Fréneaux P; Petras S; Alberini JL
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):1034-5. PubMed ID: 24562644
    [No Abstract]   [Full Text] [Related]  

  • 16. Spectrum of FDG PET/CT findings of uterine tumors.
    Kitajima K; Murakami K; Kaji Y; Sugimura K
    AJR Am J Roentgenol; 2010 Sep; 195(3):737-43. PubMed ID: 20729454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
    Kumar R; Hawkins RA; Yeh BM; Wang ZJ
    Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-18 fluorodeoxyglucose uptake in leiomyomatous uterus.
    Shida M; Murakami M; Tsukada H; Ishiguro Y; Kikuchi K; Yamashita E; Kajiwara H; Yasuda M; Ide M
    Int J Gynecol Cancer; 2007; 17(1):285-90. PubMed ID: 17291269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High metabolic characteristics of uterine fibroids in 18F-FDG PET/CT imaging and the underlying mechanisms.
    Ma Y; Shao X; Shao X; Wang X; Wang Y
    Nucl Med Commun; 2016 Nov; 37(11):1206-11. PubMed ID: 27281358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign uterine uptake of FDG: a case report and review of literature.
    Vriens D; de Geus-Oei LF; Flucke UE; van der Kogel AJ; Oyen WJ; Vierhout ME; van der Meer JW
    Neth J Med; 2010 Sep; 68(9):379-80. PubMed ID: 20876921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.